Vivimed Of India Acquires Spanish API Maker Uquifa For $55 Million
This article was originally published in PharmAsia News
India’s Vivimed Labs says it has paid $55 million to acquire Spain-based Uquifa, a maker of active pharmaceutical ingredients that also has a presence in Mexico.
You may also be interested in...
Abbott reported third-quarter 2020 global sales of $8.9bn, driven by its strong position in COVID-19 tests. See what Abbott’s CEO Robert Ford said about it here.
From enforced detention to hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Ahead of the vaccine advisory committee, requests to FDA range from public health groups opposing emergency use authorizations to industry seeking labeling guidance on EUA products.